跳至主要内容
临床试验/ISRCTN66678006
ISRCTN66678006已完成未知

A multi-centre observational study of relapsing-remitting multiple sclerosis (RRMS) treated with first disease modifying therapies (DMTs) in current UK clinical practice: patterns of clinical decision making and the patient experience of relapse

ovartis Pharmaceuticals Ltd (UK)0 个研究点目标入组 150 人开始时间: 2012年7月26日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
150

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

性别
All

入选标准

  • 1. Patients with RRMS by 2005 MacDonald criteria
  • 2. Patients initiated on DMT for the first time after 1 January 2008 and at least 36 months before date of screening for inclusion
  • 3. Patients who consent to complete the questionnaire and for their medical records to be reviewed for the purposes of healthcare research
  • 4. Patients who are able to complete the study questionnaires or have a carer who is able and willing to record the patient?s responses to the study questionnaires

排除标准

  • 1. Patients who are unwilling or unable to provide patient consent
  • 2. Patients who are unable to complete the study questionnaires themselves and have no appropriate carer able and willing to assist them

研究者

发起方
ovartis Pharmaceuticals Ltd (UK)

相似试验